Transplanted Murine Tumours SPECT Imaging with 99mTc Delivered with an Artificial Recombinant Protein
Authors:
- Natalia V. PozdniakovaNatalia V. Pozdniakova
- Alexey A. LipengoltsALAlexey A. Lipengolts
- Vsevolod A. SkribitskyVSVsevolod A. Skribitsky
- Kristina E. ShpakovaKSKristina E. Shpakova
- Yulia A. FinogenovaYFYulia A. Finogenova
- Anna V. SmirnovaASAnna V. Smirnova
- Alexei B. ShevelevASAlexei B. Shevelev
- Elena Y. GrigorievaEGElena Y. Grigorieva
Preprint
- 9 August 2024
- preprint
- Published by MDPI AG in Preprints.org
Abstract
99mTc is a well-known radionuclide widely used and readily available for medical imaging. Despite this, the 99mTc isotope is rarely utilized for tumour imaging due to the lack of agents that can selectively deliver it to tumours. However, the use of immunologically compatible recombinant proteins, which combine metal-binding sites and tumour-specific ligands, shows promise for utilizing 99mTc in the early detection of tumours. To illustrate this, a protein called E1b, containing a metal binding center with ELP repeats, tumour-specific ligands recognizing integrin αvβ3 and nucleolin, as well as a short Cys-rich sequence, was artificially designed. This protein was produced in E. coli and purified to homogeneity using metal-chelate chromatography. In experiments, C57Bl/6 and Balb/C mice with subcutaneously grafted lung carcinoma (LLC) or mammary gland adenocarcinoma (Ca755, EMT6, or 4T1) were used to test 99mTc-E1b selectivity and the kinetics of isotope retention. The mice were intravenously injected with approximately 80 MBq of 99mTc in complex with E1b, which had been freshly purified using gel-chromatography. The biodistribution of the labeled protein was then studied using the SPECT/CT imaging method within 24 h. The ratio of radionuclide distribution in the tumour versus the adjacent normal tissue (T/N) steadily increased over the 24-h period, reaching 15.7±4.2 for EMT6, 16.5±3.8 for Ca755, 6.7±4.2 for LLC, and 7.5±3.1 for 4T1.Keywords
All Related Versions
This publication has 27 references indexed in Scilit:
- Myosin 1e deficiency affects migration of 4T1 breast cancer cellsCytoskeleton, 2023
- Preclinical Evaluation of 99mTc-MAG3-5-Fab Targeting TREM2 in Lung Cancer Mouse Models: A Comparison with 99mTc-MAG3-5-F(ab′)2Molecular Pharmaceutics, 2023
- Proteins Secreted by Lung Cancer Cells Induce the Onset of Proteinuria via Focal Adhesion Kinase Signaling in MiceLaboratory Investigation, 2023
- Spectrophotometric determination of reaction rates and kinetic parameters of a BAHD acyltransferase using DTNB (5,5′-dithio-bis-[2-nitrobenzoic acid])Plant Science, 2018
- Characterization of the Attenuation of Breast Cancer Bone Metastasis in Mice by Zoledronic Acid Using 99mTc bone ScintigraphyPathology and Oncology Research, 2014
- Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon γCancer Immunology, Immunotherapy, 2000
- A new method of technetium-99m labeling of monoclonal antibodies through sugar residues. A study with TAG-72 specific CC-49 antibodyNuclear Medicine and Biology, 1993
- The labeling of DTPA-coupled proteins with 99mTcThe International Journal of Applied Radiation and Isotopes, 1984
- Establishment of a cloned line of Lewis lung carcinoma cells adapted to cell cultureCancer Letters, 1980
- The effect of surgery and pretreatment or posttreatment adjuvant chemotherapy on primary tumor growth in an animal modelJournal of Surgical Oncology, 1975